Illumina Pursues a $20B Market

April 29, 2015 | Illumina, one of the most important companies in biomedicine, is still barely known to the public. But scientists, diagnostics makers, physicians, and Wall Street look at the company with a mix of fear and awe. Just as Intel became the company that sparked so much of the computer revolution, Illumina is driving the genomics revolution. Forbes